Sign Up
Stories
FDA Warns on Ozempic Fake Units
Share
Biopharma Innovations in Obesity and Mus...
Diabetes Drug Markets' Growth and Domina...
Eli Lilly's Diabetes and Obesity Unit Le...
Anti-Obesity Meds' Impact on Allurion Pr...
Biden's $35 Insulin Price Cap
Counterfeit Ozempic Pills Spark Hypoglyc...
Overview
API
FDA warns about thousands of fake Ozempic units, affecting five people and prompting lawsuits from Novo Nordisk against med spas selling counterfeit drugs.
Ask a question
How might the legal action impact the reputation of the affected med spas?
What are the potential long-term consequences for the weight loss drug industry?
What measures can be taken to prevent the spread of counterfeit drugs?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Sep 2023
Oct 2023
Nov 2023
Coverage